A survey shows doctors are looking to upgrade their EHR systems to better support value-based care by collecting patient outcome data and integrating with AI.
Close-up of stethoscope on a stack of money - generated with Adobe Firefly
The transition to value-based care will require changes in the electronic health record (EHR) systems physicians are using. Meanwhile, documenting clinical quality and sharing data are 2 needs driving intentions to upgrade technology in health care practices over the next 18 months.
Health care information technology analyst Black Book Research, LLC, published results of its 2024 user surveys. It included evaluations of 120 EHR vendors and 18 performance indicators regarding the functionality of practitioner platforms offering EHRs, revenue cycle management (RCM), practice management, telehealth, interoperability, patient engagement, and analytics. “Updated EHR and RCM technologies to meet the evolving demands of this paradigm are leading to positive patient outcomes,” Black Book President Doug Brown said in a news release from News Wire.1
But 82% of physicians said their EHR systems do not have technology to be evaluated based on factors such as patient satisfaction, clinical outcomes, adherence to evidence-based practices, and overall cost-effectiveness, according to Black Book. A full 85% of physicians confirmed BAIVECTOR (top pattern); Visual Generation (illustration) - stock.adobe.com their practice needs to be updated with better technology to collect, analyze, and report patient outcomes, costs, and quality of care.
Most physicians (54%) said their existing systems have been improved to involve patients in care plans, but 83% said the current technologies are inadequate for participating in value-based care plans. Almost all (96%) said they want artificial intelligence (AI) and machine learning applications to enhance their EHRs as early as this year, and more than 60% said any upcoming EHR acquisitions or replacements will include AI utilities.
Physicians in primary care and aligned specialties offered high ratings for these systems: Elation, Practice Fusion EHR (Veradigm), Gehrimed (Netsmart), athenahealth, ModMed, and Greenway Health. Among medical groups with 10 or more physicians, 41% said they planned to upgrade or replace current practice management software in the next 18 months. They indicated they want features not in the current systems. “Two of the major drivers behind the technology transformations are in response to health care industry developments such as the need to document clinical quality to achieve optimized revenue benefits and the intensified requirements for data sharing to coordinate care to ready organizations for value-based care capitation,” mentioned in a Black Book Research news release.2
For full article and more, visit https://bit.ly/3UJPlg6
Leon-Ferre Explores Targeting of PIK3CA Alterations in ER+ Breast Cancer
July 24th 2024During a live Community Case Forum event in partnership with the Minnesota Society of Clinical Oncology, Roberto A. Leon-Ferre, MD, discussed drugs targeting PIK3CA alterations in patients with ER+ metastatic breast cancer.
Read More
Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer
July 23rd 2024In separate, live virtual events, Michael J. Birrer, MD, PhD, and Jubilee Brown, MD, surveyed participants on the treatment of a postmenopausal woman with stage IVA endometrial cancer after first-line chemotherapy.
Read More
George Explores Impact of Risk Status With Cabozantinib/Nivolumab in Advanced RCC
July 19th 2024During a Case-Based Roundtable® event, Daniel George, MD, discussed the results of the CheckMate 9ER trial across favorable, intermediate, and poor risk groups in patients with advanced renal cell carcinoma.
Read More
Depth of Response With Quadruplet Regimens Considered in Newly Diagnosed Multiple Myeloma
July 18th 2024During a Case-Based Roundtable® event, Timothy Schmidt, MD, and participants discussed treatment selection for a 54-year-old patient with transplant eligible R-ISS stage 2/R2-ISS stage 3 IgG-κ myeloma.
Read More
Rossetti Reviews Myelofibrosis Risk Stratification and Outcome Data for Pacritinib
July 17th 2024During a Case-Based Roundtable® event, James M. Rossetti, DO, discussed the role of risk scoring and stratification tools and treatment for a patient with declining hemoglobin and platelet counts due to primary myelofibrosis.
Read More